Neion Bio, a biotechnology company revolutionizing the production of biologic medicines, today announced the appointment of James Kehler, VMD, PhD, as Head of Avian Sciences. Dr. Kehler joins Neion ...

The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...

This genetic condition that affects millions - especially men - can shape daily life and career choices.

Forge Genetics have finalised a significant licensing deal with AbbVie, a global biopharmaceutical company. The contract, comprising an upfront payment followed by development milestone payments, ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired an exclusive worldwide license to a patented ...

Two flavors of twin-turbo Cadillac for under $20,000.

The field of plant-microbiome interactions is emerging as a pivotal area in understanding how plants adapt to the accelerating challenges posed by climate ...

The main market opportunities lie in advancing protein engineering to develop innovative protein-based therapeutics, capitalizing on the pharmaceutical sector's demand for enhanced enzymes. This field ...

A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.

Regeneron Pharmaceuticals plans to expand its pipeline into radiopharmaceutical therapies through an up to $4.3 billion collaboration with Telix Pharmaceuticals to co-develop and co-commercialize ...

Software engineering has experienced two seismic shifts this century. First was the rise of the open source movement, which ...